New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its.
EQS-News: Andera Partners / Key word(s): Funds Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros 16.02.2023 / 09:00 CET/CEST The issuer is solely responsible for the content of this announceme.
EQS-News: Andera Partners / Key word(s): Financing Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension 10.01.2023 / 08:30 CET/CEST The issuer is solely responsible for the content of this announcement. Andera Partners invests in S.
/PRNewswire/ SoniVie Ltd. ("SoniVie" or the "Company"), a medical device company developing a proprietary solution to treat hypertension, announced today.